Scientists define important gene interaction that drives aggressive brain cancer
2014-12-11
(Press-News.org) Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
In a study recently published in the journal Neuro-Oncology, a team of scientists led by Luni Emdad, M.B.B.S., Ph.D., and Paul B. Fisher, M.Ph., Ph.D., provided the first evidence of an important link between a specific microRNA, miR-184, and a cancer promoting gene, SND1, in the regulation of malignant glioma. miR-184 is known to suppress tumor development by regulating a variety of genes involved in cancer growth, while SND1 has been shown to play a significant role in the development of breast, colon, prostate and liver cancers. Through a variety of preclinical experiments, the team demonstrated that increasing the expression of miR-184 slows the growth and invasive characteristics of glioma cells through direct regulation of SND1. Additionally, they showed that reduced levels of SND1 led to reduced levels of STAT3, a gene that has been shown to promote the most lethal characteristics of brain cancer.
"Patients suffering from brain tumors are in desperate need of improved therapies," says Fisher, Thelma Newmeyer Corman Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics research program at VCU Massey Cancer Center, chairman of the Department of Human and Molecular Genetics at VCU School of Medicine and director of the VIMM. "We're hopeful that this new understanding of the relationship between miR-184 and SND1 ultimately will lead to the development of new drugs that reduce SND1 expression and improve patient outcomes."
Prior studies have shown that levels of miR-184 are unusually low in tissue samples from patients with malignant gliomas. Using advanced computer analysis techniques designed to study and process biological data, the researchers identified SND1 among a handful of other genes that miR-184 helps regulate. Knowing SND1 is implicated in a variety of cancers and having previously defined its role in liver cancer, Emdad, Fisher and their colleagues explored this relationship further. They confirmed low levels of miR-184 expression in human glioma tissue samples and cultured cell lines as well as an increase in the expression of SND1 compared to normal brain tissue. Using data from a large public brain tumor database called REMBRANDT, the researchers confirmed that patients with lower levels of SND1 survived longer than those with elevated SND1 expression.
"We still have a long way to go and many challenges to overcome before we will have therapies that are ready for clinical use, but this is a significant first step in the process," says Emdad, member of the Cancer Molecular Genetics research program at Massey, assistant professor in the VCU Department of Human and Molecular Genetics and member of the VIMM. "Future studies will aim to explore the relationship between SND1 and STAT3, identify additional microRNAs that may be relevant to malignant glioma and explore the effects of drugs that block SND1 expression in more advanced preclinical models."
INFORMATION:
Fisher and Emdad collaborated with Devanand Sarkar, M.B.B.S., Ph.D., Harrison Scholar and member of the Cancer Molecular Genetics research program at Massey, Blick Scholar and associate professor in the Department of Human and Molecular Genetics at the VCU School of Medicine and member of the VIMM; Swadesh K. Das, Ph.D., member of the Cancer Molecular Genetics research program at Massey, member of the VIMM and assistant professor in the VCU Department of Human and Molecular Genetics; Mitchell E. Menezes, Ph.D., Prasanna K. Santhekadur, Ph.D., and Bin Hu, Ph.D., all postdoctoral research scientists in the VCU Department of Human and Molecular Genetics; and Aleksandar Janjic, Mohammad Al-Zubi and Xue-Ning Shen, all research technicians in the VCU Department of Human and Molecular Genetics and the VIMM.
The full manuscript of this study is available online at: http://www.ncbi.nlm.nih.gov/pubmed/25216670.
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-11
Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer. As they age, however, many experience impaired thinking, memory loss, mood swings and other evidence of impaired mental function.
To stop these changes, scientists have to learn what is causing them. One possibility researchers are considering is that long-term infections with other pathogens, common in HIV-positive patients, are affecting the brain. But a new study has eliminated one of their prime suspects: the hepatitis C virus, which infects ...
2014-12-11
Lincoln, Neb., Dec. 11, 2104 -- A University of Nebraska-Lincoln researcher has contributed to discoveries about bird evolution as part of a new study that sequenced the complete genomes of 45 avian species.
Published Dec. 11 in the journal Science, the study found that avian genomes -- the complete archive of genetic material present in cells -- have exhibited surprisingly slow rates of evolution when compared with their mammalian counterparts.
Jay Storz, a Susan J. Rosowski Associate Professor of Biological Sciences, led a research group that assisted the study by examining ...
2014-12-11
The fruits and vegetables provided at school deliver an important dietary boost to low income adolescents, according to Meghan Longacre, PhD and Madeline Dalton, PhD of Dartmouth Hitchcock's Norris Cotton Cancer Center and The Hood Center for Children and Families. In a study released in Preventive Medicine, Longacre and Dalton found that fruit and vegetable intake was higher among low income adolescents on days when they consumed meals at school compared to days when low income adolescent were not in school. The opposite was true for high income adolescents who consumed ...
2014-12-11
PITTSBURGH--The 2013 Boston Marathon bombing motivated mass expressions of fear, solidarity, and sympathy toward Bostonians on social media networks around the world. In a recently released study, researchers at the University of Pittsburgh and Cornell University analyzed emotional reactions on Twitter in the hours and weeks following the attack.
The study is the first large-scale analysis of fear and social-support reactions from geographically distant communities following a terrorist attack. The findings show the extent to which communities outside of Boston expressed ...
2014-12-11
Origami is capable of turning a simple sheet of paper into a pretty paper crane, but the principles behind the paper-folding art can also be applied to making a microfluidic device for a blood test, or for storing a satellite's solar panel in a rocket's cargo bay.
A team of University of Pennsylvania researchers is turning kirigami, a related art form that allows the paper to be cut, into a technique that can be applied equally to structures on those vastly divergent length scales.
In a new study, the researchers lay out the rules for folding and cutting a hexagonal ...
2014-12-11
A CEO's natural sunny disposition can have an impact on the way the market reacts to announcements of company earnings, according to research from the University of British Columbia's Sauder School of Business.
The study shows that leaders' inclinations to express themselves with optimism carries over into their tone when disclosing company performance - a tendency that can create an uptick in stock price.
"Ours is the first study to look at the effect of how managers naturally convey themselves," says Sauder Assistant Professor Jenny Zhang, who co-authored the paper. ...
2014-12-11
Senescent cells have a bad-guy reputation when it comes to aging. While cellular senescence - a process whereby cells permanently lose the ability to divide when they are stressed - suppresses cancer by halting the growth of premalignant cells, it is also suspected of driving the aging process. Senescent cells, which accumulate over time, release a continual cascade of inflammatory cytokines, chemokines, growth factors and proteases. It is a process that sets up the surrounding tissue for a host of maladies including arthritis, atherosclerosis and late life cancer. But ...
2014-12-11
The ascetic and moralizing movements that spawned the world's major religious traditions--Buddhism, Islam, Judaism, Hinduism, and Christianity--all arose around the same time in three different regions, and researchers reporting in the Cell Press journal Current Biology on December 11 have now devised a statistical model based on history and human psychology that helps to explain why. The emergence of world religions, they say, was triggered by the rising standards of living in the great civilizations of Eurasia.
"One implication is that world religions and secular spiritualities ...
2014-12-11
EMBARGOED for release Thursday, Dec. 11, 2014, at 12 p.m. ET
HOUSTON - (Dec. 11, 2014) - The ancient Japanese art of origami is based on the idea that nearly any design - a crane, an insect, a samurai warrior - can be made by taking the same blank sheet of paper and folding it in different ways.
The human body faces a similar problem. The genome inside every cell of the body is identical, but the body needs each cell to be different -an immune cell fights off infection; a cone cell helps the eye detect light; the heart's myocytes must beat endlessly.
Appearing online ...
2014-12-11
Clinical trials to test the new drugs in patients should begin as early as 2015.
Existing drugs target faulty versions of a protein called BRAF which drives about half of all melanomas, but while initially very effective, the cancers almost always become resistant to treatment within a year.
The new drugs - called panRAF inhibitors - could be effective in patients with melanoma who have developed resistance to BRAF inhibitors.
The new study was funded by the Wellcome Trust and Cancer Research UK, and jointly led by scientists at The Institute of Cancer Research, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Scientists define important gene interaction that drives aggressive brain cancer
